Trump gets blamed for economic woes, the Corporate Transparency Act returns, financial implications of reclassifying ...

Retail inflows into U.S. stocks are set to hit a record in 2025, as individual investors become a major force behind a rally ...

Thomas Kelly, 33, left medicine to build an AI tool to help doctors with their heavy workloads. Today, his company is worth ...

After eight months spent tweaking its surveillance drone in Ukraine, demand for Shield AI’s V-BAT is ramping up in Europe and ...

Even as AI roles increase, mentions of the technology in job listings are down. It's a sign that bosses already expect you to ...

The proposal (SB 482) includes such things as steps to keep “harmful” content from minors and is being dubbed the “Artificial Intelligence Bill of Rights.” ...

Taiwan will likely hold its policy rate for the seventh straight quarter — the longest stretch since 2021 — as the economy ...

AI has been the buzzword on Wall Street for nearly all of 2025, but Medline's IPO is catching the eye of investors.

Many tech startups that raised money at inflated valuations during the 2021 bubble are now struggling as market multiples ...

After taking a shot at becoming a neuroscience biotech, buzzy Bay Area AI outfit Verge Genomics is dropping its only clinical ...

A group of private equity firms led by Permira and Warburg Pincus has clinched a deal to acquire investment and accounting ...

More drops for AI stocks are dragging the U.S. market lower, and Wall Street is heading toward a fourth straight loss. The ...